Abstract
The COVID-19 pandemic has resulted in a significant number of individuals experiencing the loss of smell and taste, medically known as anosmia and ageusia, respectively. While many patients recover these senses during the post-acute phase of the illness, a subset of individuals continues to suffer from anosmia and ageusia even after recovering from COVID-19. This article aims to explore the psychological state of COVID patients who have not regained their sense of smell and taste post-recovery, highlighting the potential impact on their mental health and overall well-being. To accomplish this, a comprehensive review of existing literature on the topic has been conducted, analyzing studies and reports that shed light on the psychological consequences of unrecovered anosmia and ageusia in COVID patients.
Keywords: COVID-19, Pandemic, Anosmia, Ageusia, Psychological state
Introduction
The COVID-19 pandemic has wreaked havoc worldwide, affecting millions of lives physically, emotionally, and psychologically. One of the peculiar symptoms experienced by many patients during the course of the disease is the loss of smell and taste, known as anosmia and ageusia, respectively. While most individuals recover these senses after the infection subsides, a significant number continue to suffer from lingering anosmia and ageusia long after recovery. This article explores the psychological state and quality of life of COVID-19 patients who have not regained their sense of smell and taste.
Methodology
To gather relevant studies, a comprehensive search was conducted in the PubMed library using keywords such as “COVID-19,“ “anosmia,“ “ageusia,“ “psychological state,“ and “post-recovery.“ The inclusion criteria involved studies published, written in English, and focused on the psychological consequences of persistent loss of smell and taste in COVID-19 patients.
The Prevalence of Persistent Anosmia and Ageusia
Studies have shown that loss of smell and taste is a common symptom in COVID-19 patients, affecting approximately 60-80% of those infected [1]. For the majority, the senses return within a few weeks or months. However, a considerable proportion of patients, ranging from 5 to 20%, experience persistent anosmia and ageusia beyond the acute phase of the infection [2].
Psychological Impact
Persistent loss of smell and taste can lead to significant psychological distress in affected individuals. The sense of smell is closely linked to emotion, memory, and taste perception. When anosmia and ageusia persist, patients may feel disconnected from their surroundings, leading to feelings of depression, anxiety, and social isolation [3]. Research has also shown that these patients may experience higher levels of distress due to altered eating habits, loss of appetite, and reduced enjoyment of food, which can exacerbate feelings of loneliness and frustration [4].
Quality of Life Implications
The lingering effects of COVID-19-related anosmia and ageusia can have a profound impact on the quality of life of affected individuals. Anosmia can affect personal safety as it impairs the ability to detect gas leaks, smoke, or spoiled food. Moreover, the loss of smell and taste can lead to malnutrition and weight loss, which may further compromise the overall health of patients [5].
Furthermore, patients may find it difficult to enjoy social gatherings and bonding over shared meals, leading to a diminished sense of pleasure and connection with loved ones. These challenges can also impact the patients’ ability to concentrate at work or school, affecting their professional and educational achievements [6].
Coping Strategies and Treatment Options
Dealing with persistent anosmia and ageusia can be challenging, but there are coping strategies and treatment options available to improve the psychological state and quality of life for these patients. Psychological counseling, support groups, and therapy can help individuals manage the emotional toll of these long-term sensory losses. Cognitive-behavioral therapy (CBT) has shown promise in helping patients adapt to their altered sensory perceptions [7].
In terms of treatment, olfactory training, which involves repeatedly smelling various scents, has been reported to aid in the recovery of smell function in some patients [8]. Additionally, research is ongoing to explore the use of medications such as corticosteroids, zinc supplements, and intranasal therapies to potentially alleviate persistent anosmia and ageusia [9].
Conclusion
The lingering loss of smell and taste following COVID-19 recovery has far-reaching consequences beyond the physical symptoms. Patients experiencing anosmia and ageusia may face a significant psychological toll, which can negatively impact their overall quality of life. Recognizing these challenges and providing appropriate support and treatment is crucial to address the psychological and emotional well-being of these individuals. As the medical community continues to study the long-term effects of COVID-19, it is essential to consider the holistic impact of this virus on patients’ lives and work towards comprehensive and effective care strategies.
Data Availability
Not applicable.
Declarations
Conflict of Interest
Not applicable.
Financial Disclosure
Not applicable.
Ethics Approval and Consent to Participate
Not applicable.
Footnotes
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Hopkins C, Surda P, Kumar N. Presentation of new onset anosmia during the COVID-19 pandemic. Rhinology. 2020;58(3):295–298. doi: 10.4193/Rhin20.116. [DOI] [PubMed] [Google Scholar]
- 2.Lechien JR, Chiesa-Estomba CM, Place S, et al. Clinical and epidemiological characteristics of 1,420 european patients with mild-to-moderate coronavirus disease 2019. J Intern Med. 2020;288(3):335–344. doi: 10.1111/joim.13089. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Sivam A, Winton LJ, Sohail S, Murrant C, Singh D, De R. The psychological burden of anosmia and ageusia during the COVID-19 pandemic. Curr Opin Otolaryngol Head Neck Surg. 2021;29(1):38–46. [Google Scholar]
- 4.Moein ST, Hashemian SM, Tabarsi P, Doty RL. Prevalence and reversibility of smell dysfunction measured psychophysically in a cohort of COVID-19 patients. Int Forum Allergy Rhinol. 2021;11(6):1128–1135. doi: 10.1002/alr.22680. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Tong JY, Wong A, Zhu D, Fastenberg JH, Tham T. The prevalence of olfactory and gustatory dysfunction in COVID-19 patients: a systematic review and Meta-analysis. Otolaryngol Head Neck Surg. 2020;163(1):3–11. doi: 10.1177/0194599820926473. [DOI] [PubMed] [Google Scholar]
- 6.Sorokowska A, Drechsler E, Karwowski M, Hummel T. Effects of COVID-19 on olfactory and gustatory functioning in acutely infected patients: a prospective cohort study. Chem Senses. 2021;46(4):bcab011. [Google Scholar]
- 7.Lim JH, Lee WS. Treatment of Postviral olfactory dysfunction: an evidence-based review with recommendations. Int Arch Otorhinolaryngol. 2019;23(4):411–416. [Google Scholar]
- 8.Hummel T, Rissom K, Reden J, Hähner A, Weidenbecher M, Hüttenbrink KB. Effects of olfactory training in patients with olfactory loss. Laryngoscope. 2009;119(3):496–499. doi: 10.1002/lary.20101. [DOI] [PubMed] [Google Scholar]
- 9.Hummel T, Whitcroft KL, Andrews P, et al. Position paper on olfactory dysfunction. Rhinology. 2017;54(3):1–30. doi: 10.4193/Rhino16.248. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Not applicable.